Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer (Q74222602)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

main subject

phase II clinical trial

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

7

E Vokes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

T Lad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Rosen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D Sciortino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Brockstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J P Keubler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Arietta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

261-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10958595%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006481924287

9 November 2019

exact match

0 references

cites work

A phase II study of topotecan in patients with recurrent head and neck cancer. Identification of an active new agent

1 reference

12 December 2020

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

12 December 2020

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

12 December 2020

Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription

1 reference

12 December 2020

Phase II study of topotecan in metastatic non-small-cell lung cancer

1 reference

12 December 2020

Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

1 reference

12 December 2020

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

12 December 2020

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

12 December 2020

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy

1 reference

12 December 2020

Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck. A phase II Southwest Oncology Group study

1 reference

12 December 2020

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

12 December 2020

A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer

1 reference

12 December 2020